Insider · CIK 0002095697
Innovative Cellular Therapeutics Holdings Ltd
Files at LYEL (Lyell Immunopharma, Inc.). First filing Jul 17, 2026, latest Jul 20, 2026.
In brief
Innovative Cellular Therapeutics Holdings Ltd files SEC Form 4 as 10% owner at LYEL (Lyell Immunopharma, Inc.). Since Jul 17, 2026, Innovative Cellular Therapeutics Holdings Ltd has reported 0 open-market buys worth $0 and 2 open-market sells worth $274, the latest filed on Jul 20, 2026.
A track record needs three past buys with six months of prices behind them; Innovative Cellular Therapeutics Holdings Ltd has 0, so none is measured yet.
The newest scored trade: sold $137 of LYEL on Jul 17, 2026, filed Jul 20, 2026, scored 0 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 2 sells worth $274.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
LYEL: Lyell Immunopharma, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 0Weak | Lyell Immunopharma, Inc. | $137 10 shares | -0% | +44% from low-65% from high | |
| 0Weak | Lyell Immunopharma, Inc. | $137 10 shares | -0% | +50% from low-64% from high |
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 27, 2026 | LYEL Lyell Immunopharma, Inc. | JOther Common Stock | -38,500 | $0.00 | $0 | 2,818,980 | Jul 27, 2026 |
| Jul 27, 2026 | LYEL Lyell Immunopharma, Inc. | JOther Common Stock | -44,000 | $0.00 | $0 | 2,774,980 | Jul 27, 2026 |
| Jul 17, 2026 | LYEL Lyell Immunopharma, Inc. | SOpen-market sale Common Stock10b5-1 | -10 | $13.70 | $137 | 2,857,480 | Jul 20, 2026 |
| Jul 16, 2026 | LYEL Lyell Immunopharma, Inc. | SOpen-market sale Common Stock10b5-1 | -10 | $13.73 | $137 | 2,857,490 | Jul 17, 2026 |
| Jun 29, 2026 | LYEL Lyell Immunopharma, Inc. | JOther Common Stock | -76,000 | $0.00 | $0 | 2,857,500 | Jul 1, 2026 |
| Jun 15, 2026 | LYEL Lyell Immunopharma, Inc. | JOther Common Stock | -66,500 | $0.00 | $0 | 2,933,500 | Jun 18, 2026 |
Questions about Innovative Cellular Therapeutics Holdings Ltd
Answered from the filings on this page, as of the latest one.
Is Innovative Cellular Therapeutics Holdings Ltd buying or selling?
In the last 12 months Innovative Cellular Therapeutics Holdings Ltd reported 0 open-market buys worth $0 and 2 open-market sells worth $274 on SEC Form 4; the latest was sold $137 of LYEL on Jul 17, 2026. Grants, option exercises and tax withholding are not counted.
How did Innovative Cellular Therapeutics Holdings Ltd's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Innovative Cellular Therapeutics Holdings Ltd has 0.
Where does Innovative Cellular Therapeutics Holdings Ltd file Form 4?
Innovative Cellular Therapeutics Holdings Ltd has filed Form 4 at LYEL (Lyell Immunopharma, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.